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The maximum displacement in mm had no influence on acute 
GI toxicity (p=0.63) nor acute GU toxicity (p=0.73). 
For both acute GI (p=0.36) and GU (p=0.56) toxicity the 
number of displacements was not statistically significant. 
No statistically significant differences were seen in late GI 
toxicity between NDP (9.4%) and DP (8.6%) (p=1.0), while late 
GU toxicity was significantly higher in NDP (30%) versus DP 
(16%) (p=0.04). However, in a multivariate analysis including 
risk factors; age, baseline toxicity, IPSS, Comorbidity, 
number of needles, and prostate volume, the difference in 
late GU between the DP and NDP was not significant anymore 
(P=0.08). 
The influence of maximum displacement was not significant 
for late GI (p=0.71) nor GU (p=0.49) toxicity. 
The number of displacements was also not significantly 
associated with both late GI (p=0.73) and GU (p=0.60) 
toxicity. 
Conclusions: Corrected displacement during the 4 fractions 
regimen of HDR monotherapy did not lead to an increase in 
acute nor late GI and GU toxicity confirming the feasibility of 
our correction protocol to ensure a safe HDR treatment 
regimen. 
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Purpose/Objective: To evaluate the efficacy of CT-guided 
radioactive seed implantation for locally recurrent rectal 
cancer (LRRC) , and analyze the associated prognostic 
factors. 
Materials and Methods: From September 2003 to October 
2014, 97 patients with locally recurrent rectal cancer 
received 125I seeds implantation under CT guidance in our 
center. Each patient underwent three-dimentional treatment 
planning pre-implantation and dosimetric verification post-
implantation. The range of activity of seed was from 0.40 to 
0.8 mCi, and the range of seeds number was from 18 to 137. 
The range of D90 was from 75.91 to 165.27 Gy. Overall 
survival of the patients was calculated and prognostic factors 
were evaluated. 
Results: The follow-up rate was 93.5%, the median follow-up 
time was 15.7 months (4.2 ~ 98.1 months). The response rate 
of pain relief was 95.2%. The overall response rate was 
51.6%, in which complete response rate was16.1% and partial 
response rate was 35.5%. The 1, 2 and 3 year local control 
rates were 32.3%, 11.3% and 11.3%, respectively. The median 
local control time was 8.0 month. The 1, 2 and 3 year 
survival rates were 67.6%, 36.0%and 7.5%, respectively. The 
median overall survival time was 21.5 months. Analysis using 
the Cox proportional hazards model suggested that patients 
with pre-sacral recurrence and patients who received a D90 
higher than 140 Gy may survive for a longer period. 
Conclusions: CT-guided radioactive seed implantation 
provides a safe and effective method to relieve pain, control 
local tumor growth and, to some extent, prolong the survival 
of patients with locally recurrent rectal cancer without 
additional complications. It is an alternative treatment 
option for locally recurrent rectal cancer, especially for 
those with previous pelvic radiation. Location of recurrent 
tumor and accumulated dose may be factors predictive of a 
favorable outcome for patients. These findings need to be 
validated by conducting further studies with larger cohorts.  
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Purpose/Objective: Surface mould brachytherapy (SMB) is a 
century old technique which can be used for various sites 
such as skin, nose, ear and hard palate in the head and neck 
region. There is scarcity of data on high dose rate (HDR) SMB. 
Aim of this study is to evaluate the outcomes of patients 
treated with SMB technique. 
Materials and Methods: Patients with malignant localized 
early T1 or T2, node negative lesions in the head and neck 
region treated with SMB during 2008-2013 were considered. 
Individualized mould was prepared for all patients. Three 
dimensional CT based planning was carried out with the 
mould in situ using the Plato planning system (Nucletron). 
The median number of catheters was 5 (Range 3-7). 
Treatment was delivered using HDR 192 Ir source to a dose 
ranging from 39 to 52.5 Gy (mean 49 Gy) with 350cGy per 
fraction, using bid regimen. Median number of catheters used 
were 5 (range 3 to 7). For the present analysis the data was 
extracted from a prospective brachytherapy database as well 
as from patient charts. The data was analysed using SPSS 
software (V18). Survival analysis was done using Kaplan Meier 
method. 
Results: Thirty one patients were treated with SMB. The 
median age at presentation was 53 years (range 25-82 years). 
Most of the patients were males (n=24). The most common 
site was hard palate in 14 (45%), followed by nose in 7 
(22.5%), soft palate in 5 (16%), tonsil in 2 (6.5%), skin over 
face in 2 (6.5%) and pinna 1 (3.5%). The histology was 
squamous carcinoma in 27 patients, while the rest were basal 
cell carcinoma. The median tumor size was 2 cm. Treatment 
was given in the primary setting in 29 and recurrent setting in 
2 patients. Twenty three patients received the SMB as 
definitive, radical treatment while in 8 it was used as boost 
after external beam radiotherapy. Acute skin toxicity was 
seen in 17 patients of which 10 were grade II reactions. Acute 
mucosal reactions were seen in 19 with grade II in 10 and 
grade III in 1. Median follow up was 29 months (range 4 to 78 
months). Eight patients had recurrent disease (4 primary, 3 
isolated nodal recurrences and 1 primary and nodal 
recurrence). Two patients had died at 4 months and 14 
months. Three year DFS was 70% and 3 year overall survival 
was 91%. Grade 1 mucosal atrophy was seen in 22. Grade 1 
xerostomia was seen in 6 and grade II for 1 patient (all of 
them had received external radiotherapy). On long term 
follow up osteo- necrosis was seen for 2 of which 1 
recurrence had at the primary site. Skin hypopigmentation 
was seen in 3 while telangiectasia was seen in 9 patients. 
Conclusions: Surface mould brachytherapy results in 
acceptable locoregional control rates and good overall 
survival with excellent organ and function preservation.  
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